Three things to know:
1. TauC3 Biologics, based in London, is developing an immunotherapy to prevent or halt the spread of neurodegenerative diseases such as Alzheimer’s.
2. Dr. Virani completed his neurosurgery residency at the University of Cambridge Teaching Hospitals in England and is currently based in the San Francisco Bay area.
3. He has 15 years of experience in the life sciences industry focusing on building portfolios of companies in neuroscience, rare diseases and precision oncology.
More articles on devices:
Dr. Bryan Little appointed to state medical board, task force
Former Medtronic, Bioventus executive becomes CEO at BlueWind Medical
Exactech co-founders retire, current CEO to transition to board role — 4 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
